It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Automatically detecting and grading cancerous regions on radical prostatectomy (RP) sections facilitates graphical and quantitative pathology reporting, potentially benefitting post-surgery prognosis, recurrence prediction, and treatment planning after RP. Promising results for detecting and grading prostate cancer on digital histopathology images have been reported using machine learning techniques. However, the importance and applicability of those methods have not been fully investigated. We computed three-class tissue component maps (TCMs) from the images, where each pixel was labeled as nuclei, lumina, or other. We applied seven different machine learning approaches: three non-deep learning classifiers with features extracted from TCMs, and four deep learning, using transfer learning with the 1) TCMs, 2) nuclei maps, 3) lumina maps, and 4) raw images for cancer detection and grading on whole-mount RP tissue sections. We performed leave-one-patient-out cross-validation against expert annotations using 286 whole-slide images from 68 patients. For both cancer detection and grading, transfer learning using TCMs performed best. Transfer learning using nuclei maps yielded slightly inferior overall performance, but the best performance for classifying higher-grade cancer. This suggests that 3-class TCMs provide the major cues for cancer detection and grading primarily using nucleus features, which are the most important information for identifying higher-grade cancer.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 London Regional Cancer Program, Baines Imaging Research Laboratory, London, Canada (GRID:grid.412745.1) (ISNI:0000 0000 9132 1600); University of Western Ontario, Department of Medical Biophysics, London, Canada (GRID:grid.39381.30) (ISNI:0000 0004 1936 8884); Lawson Health Research Institute, London, Canada (GRID:grid.415847.b) (ISNI:0000 0001 0556 2414)
2 London Regional Cancer Program, Baines Imaging Research Laboratory, London, Canada (GRID:grid.412745.1) (ISNI:0000 0000 9132 1600); Lawson Health Research Institute, London, Canada (GRID:grid.415847.b) (ISNI:0000 0001 0556 2414)
3 University of Western Ontario, Department of Pathology and Laboratory Medicine, London, Canada (GRID:grid.39381.30) (ISNI:0000 0004 1936 8884)
4 University of Western Ontario, Department of Surgery, London, Canada (GRID:grid.39381.30) (ISNI:0000 0004 1936 8884); University of Western Ontario, Department of Oncology, London, Canada (GRID:grid.39381.30) (ISNI:0000 0004 1936 8884)
5 University of Western Ontario, Department of Medical Biophysics, London, Canada (GRID:grid.39381.30) (ISNI:0000 0004 1936 8884); University of Western Ontario, Department of Oncology, London, Canada (GRID:grid.39381.30) (ISNI:0000 0004 1936 8884); Lawson Health Research Institute, London, Canada (GRID:grid.415847.b) (ISNI:0000 0001 0556 2414)
6 London Regional Cancer Program, Baines Imaging Research Laboratory, London, Canada (GRID:grid.412745.1) (ISNI:0000 0000 9132 1600); University of Western Ontario, Department of Medical Biophysics, London, Canada (GRID:grid.39381.30) (ISNI:0000 0004 1936 8884); University of Western Ontario, Department of Oncology, London, Canada (GRID:grid.39381.30) (ISNI:0000 0004 1936 8884); Lawson Health Research Institute, London, Canada (GRID:grid.415847.b) (ISNI:0000 0001 0556 2414)